Infectious Diseases (except HIV/AIDS)

  1. Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in adolescents in Taiwan: A double-blind, randomized, placebo-controlled phase 2 trial

    1. Luke Tzu-Chi Liu
    2. Cheng-Hsun Chiu
    3. Nan-Chang Chiu
    4. Boon-Fatt Tan
    5. Chien-Yu Lin
    6. Hao-Yuan Cheng
    7. Meei-Yun Lin
    8. Chia-En Lien
    9. Charles Chen
    10. Li-Min Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Post-acute sequelae of covid-19 six to 12 months after infection: population based study

    1. Raphael S Peter
    2. Alexandra Nieters
    3. Hans-Georg Kräusslich
    4. Stefan O Brockmann
    5. Siri Göpel
    6. Gerhard Kindle
    7. Uta Merle
    8. Jürgen M Steinacker
    9. Dietrich Rothenbacher
    10. Winfried V Kern

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. SARS-CoV-2 Omicron disease burden in Australia following border reopening: a modelling analysis

    1. George J Milne
    2. Julian Carrivick

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Neutralizing responses in fully vaccinated with BNT162b2, CoronaVac, ChAdOx1, and Ad26.COV2.S against SARS-CoV-2 lineages in Colombia, 2020-2021

    1. Diego A. Álvarez-Díaz
    2. Ana Luisa Muñoz
    3. María T. Herrera-Sepúlveda
    4. Pilar Tavera-Rodríguez
    5. Katherine Laiton-Donato
    6. Carlos Franco-Muñoz
    7. Héctor Alejandro Ruiz-Moreno
    8. Dioselina Pelaez-Carvajal
    9. Alejandra M. Muñoz-Suarez
    10. Marisol Galindo
    11. Jhonnatan Reales-Gonzalez
    12. Jenssy D. Catama
    13. Beatriz Helena De Arco
    14. Tatiana Cobos
    15. Edgar J. Arias-Ramirez
    16. Marcela Mercado-Reyes

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure

    1. Efstratios Gavriilidis
    2. Christina Antoniadou
    3. Akrivi Chrysanthopoulou
    4. Maria Ntinopoulou
    5. Andreas Smyrlis
    6. Iliana Fotiadou
    7. Nikoleta Zioga
    8. Dionysios Kogias
    9. Anastasia-Maria Natsi
    10. Christos Pelekoudas
    11. Evangelia Satiridou
    12. Stefania-Aspasia Bakola
    13. Charalampos Papagoras
    14. Ioannis Mitroulis
    15. Paschalis Peichamperis
    16. Dimitrios Mikroulis
    17. Vasileios Papadopoulos
    18. Panagiotis Skendros
    19. Konstantinos Ritis

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Super-spreaders of novel coronaviruses that cause SARS, MERS and COVID-19: a systematic review

    1. Julii Brainard
    2. Natalia R. Jones
    3. Florence C.D. Harrison
    4. Charlotte C. Hammer
    5. Iain R. Lake

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Expiratory Aerosol pH: The Overlooked Driver of Airborne Virus Inactivation

    1. Beiping Luo
    2. Aline Schaub
    3. Irina Glas
    4. Liviana K. Klein
    5. Shannon C. David
    6. Nir Bluvshtein
    7. Kalliopi Violaki
    8. Ghislain Motos
    9. Marie O. Pohl
    10. Walter Hugentobler
    11. Athanasios Nenes
    12. Ulrich K. Krieger
    13. Silke Stertz
    14. Thomas Peter
    15. Tamar Kohn

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Broad Cross-Reactive IgA and IgG against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection

    1. Jiong Wang
    2. Bridget E. Young
    3. Dongmei Li
    4. Antti Seppo
    5. Qian Zhou
    6. Alexander Wiltse
    7. Anna Nowak-Wegrzyn
    8. Katherine Murphy
    9. Kaili Widrick
    10. Nicole Diaz
    11. Joseline Cruz-Vasquez
    12. Kirsi M. Järvinen
    13. Martin S. Zand

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Presence of Mediastinal Lymphadenopathy in Hospitalized Covid-19 Patients in a Tertiary Care Hospital in Pakistan – A cross-sectional study

    1. Faryal S. Bhatti
    2. Amyn A. Malik
    3. Adeel A. Malik

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. C allele of rs479200 of the host EGLN1 gene - a risk factor for severe COVID-19 (pilot study)

    1. Renuka Harit
    2. Sajal De
    3. Piyoosh Kumar Singh
    4. Deepika Kashyap
    5. Manish Kumar
    6. Dibakar Sahu
    7. Chander Prakash Yadav
    8. Mradul Mohan
    9. Vineeta Singh
    10. Ram Singh Tomar
    11. Kailash C Pandey
    12. Kapil Vashisht

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 185 of 716 Next